Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
- 1 November 1997
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 350 (9089), 1425-1431
- https://doi.org/10.1016/s0140-6736(97)05413-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The natural history of chronic hepatitis C in haemophiliacsBritish Journal of Haematology, 1996
- Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia populationThe Lancet, 1996
- Mortality before and after HIV infection in the complete UK population of haemophiliacsNature, 1995
- Frequent Reinfection And Reactivation Of Hepatitis C Virus Genotypes In Multitransfused HemophiliacsThe Journal of Infectious Diseases, 1994
- Low risk of transmission of hepatitis E virus by large-pool coagulation factor concentratesThe Lancet, 1994
- Seropositivity for HIV in U.K. haemophiliacsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1989
- Interferon therapy for chronic non‐A non‐B and chronic delta liver disease in haemophiliaBritish Journal of Haematology, 1989
- High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 1985
- Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom.BMJ, 1983
- Factor VIII Concentrates Made in the United Kingdom and the Treatment of Haemophilia Based on Studies Made during 1969–72British Journal of Haematology, 1974